Tricyclic drugs for depression in children and adolescents. (Q33978730)

30 July 2017

1 reference

title

Tricyclic drugs for depression in children and adolescents. (English)

1 reference

30 July 2017

Tricyclic drugs for depression in children and adolescents (English)

0 references

1 reference

P Hazell

1

1 reference

30 July 2017

D O'Connell

series ordinal

2

1 reference

30 July 2017

D Heathcote

series ordinal

3

1 reference

30 July 2017

D Henry

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

2002

0 references

published in

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

2

0 references

page(s)

CD002317

1 reference

Analog classroom assessment of Adderall in children with ADHD.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Adolescent depression: controlled desipramine treatment and atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Imipramine in prepubertal major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

School phobia: a therapeutic trial with clomipramine and short-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Childhood and adolescent depression: a review of the past 10 years. Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Psychopharmacology in child and adolescent psychiatry: a review of the past five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Psychopharmacology of child and adolescent major depression: present status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Are clinicians ahead of researchers in finding a treatment for adolescent depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Sudden death in children receiving Norpramin: a review of three reported cases and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Another sudden death in a child treated with desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002317

10.1002/14651858.CD002317

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference